Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Plasma-Themed Biotech Deal Toy

Plasma-themed crystal deal toy marking two transactions involving German blood plasma firm Biotest.

(8LKC019)
1 Image

Biotech Industry Crystal Deal Toy

Crystal deal toy marking a follow-on stock offering by Cellectar Biosciences. Based in Madison, Wisconsin, the firm develops cancer drugs and imaging tools.

(8AMF311)
1 Image

Pyramid-Shaped Crystal Deal Toy

Pyramid-shaped crystal deal toy, featuring a 3-D etched logo, marking the issue of warrants by GNI Group. GNI is a Japanese biotech firm.

(7ASK1110)
1 Image

Diamond-Shaped Crystal Tombstone

Diamond-shaped crystal tombstone marking the acquisition of CMC Biologics, a Danish biopharmaceutical contract manufacturer.

(7ALJ205)
1 Image

Biotech Financing Round Tombstone

Lucite tombstone commemorating a financing round for SutroVax. Based in Foster City, California, SutroVax is a biotech firm that specializes in antibody-drug conjugates in the treatment of cancer.

(7ALJ312)
1 Image

Jounce Therapeutics IPO Tombstone

Lucite deal tombstone marking the initial public offering of Jounce Therapeutics. The biotech firm is based in Cambridge, Massaschusetts.

(7AKL272)
1 Image

Ethanol Plant Sale Tombstone

Lucite tombstone marking the sale of ethanol plants by Abengoa bioenergy plants. The purchaser was Omaha, Nebraska-based Green Plains.

(6ADL777)
1 Image

Custom Employee Recognition Award

Custom employee recognition award presented by biopharmaceutical firm Gilead Sciences.

1 Image

Follow-on Offering Tombstone

Lucite tombstone marking a follow-on offering by RXi Pharmaceuticals, a biotech firm based in Marlborough, Massachusetts.

1 Image

Biotech Deal Toys

Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.

As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.

But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.

You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.